Ukulawula isinye namathumbu ngokuvuselela izinzwa

A BAMBA MahhalaRelease 3 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

Medtronic plc today announced it received approval from the U.S. Food and Drug Administration (FDA) for InterStim X™ ― the next generation of the InterStim™ portfolio’s recharge-free device – and it is available immediately. InterStim systems are the standard of care in advanced therapy options, and the most personalized system, to deliver sacral neuromodulation (SNM)…

eTurboNews izindatshana ezababhalisi kuphela. Ukubhalisa kuyinto MAHHALA.
Ababhalisile bangena lapha Chofoza lapha ukuze ubhalise MAHHALA

LOKHO ONGAKUTHATHE KULESI SIHLOKO:

  • InterStim systems are the standard of care in advanced therapy options, and the most personalized system, to deliver sacral neuromodulation (SNM)….
  • I-Food and Drug Administration (FDA) ye-InterStim X™ ― isizukulwane esilandelayo sedivayisi engashajwa kabusha yephothifoliyo ye-InterStim™ – futhi itholakala ngokushesha.
  • eTurboNews izindatshana ezababhalisi kuphela.

<

Mayelana umbhali

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Yabelana ku...